RO5256390 explained

RO5256390 or RO-5256390 is a drug developed by Hoffmann-La Roche which acts as an agonist for the trace amine associated receptor 1, which has been shown to block compulsive and binge-like eating behavior in rats. For this reason, it is being investigated as a potential drug to treat binge eating disorder.^{[1] [2]}

Notes and References

1. Ferragud A, Howell AD, Moore CF, Ta TL, Hoener MC, Sabino V, Cottone P . The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats . Neuropsychopharmacology . 42 . 7 . 1458–1470 . June 2017 . 27711047 . 5436108 . 10.1038/npp.2016.233 .
2. Web site: RO5256390 . MedChem Express . 11 August 2023.